The following is a summary of the SLR Investment Corp. (SLRC) Q1 2024 Earnings Call Transcript:

Financial Performance:

• SLR Investment reported net investment income of $0.44 per share in Q1 2024, marking a year-over-year growth of 7.7%.

• The company saw an increase in net asset value per share to $18.19 as of March 31, 2024 from $18.09 per share at December 31, a sequential increase of 0.6%.

• The comprehensive investment portfolio slightly declined to $3.1 billion due to $261 million originations and $340 million repayments.

• SLR Investment Corp.'s net asset value at the end of March was $992 million, with $1.2 billion of debt outstanding, resulting in a leverage of 1.16x net debt to equity.

Business Progress:

• Despite the slow pace of M&A activity and an increase in bank participation, the company was able to find attractive investment opportunities in sponsor finance and specialty finance.

• The company's diverse investment strategy encompasses asset-based lending, life sciences lending, and equipment finance.

• The firm's portfolio, primarily composed of first lien senior secured loans, showed 0.8% and 0.6% non-accrual investments on cost and fair value basis respectively.

• Future growth areas are seen in asset-based loan originations, the life sciences market, and equipment finance sectors.

• The diversity of their portfolio provides flexibility in investment decision-making, with approximately $800 million of available capital to deploy as of the end of Q1.

• The yield on the overall portfolio increased from 11.6% to 11.8% quarter-over-quarter, driven by increased returns on asset-based loan classes, with no immediate compression in specialty finance verticals anticipated.

• The company shows potential for additional 'tuck-ins', mainly within their existing asset-based lending strategies, utilizing their existing infrastructure.

More details: SLR Investment Corp IR

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.